I'm not sure what your point is here. No one is denying who collobarated to produce the article. I'm making you aware that within the article, the 28,000 patients mentioned refers to all patients receiving a MM prescription in Australia, not just MXC's patients. An article can contain wider industry data while being focused on a particular company, which is the case here...
- Forums
- ASX - By Stock
- pot stock
I'm not sure what your point is here. No one is denying who...
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
|
|||||
Last
32.0¢ |
Change
-0.010(3.03%) |
Mkt cap ! $15.48M |
Open | High | Low | Value | Volume |
34.0¢ | 34.0¢ | 32.0¢ | $6.532K | 19.88K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.5¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 0.260 |
1 | 20000 | 0.250 |
1 | 2200 | 0.230 |
1 | 4761 | 0.210 |
1 | 14600 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 5000 | 1 |
0.365 | 11738 | 3 |
0.370 | 2000 | 1 |
0.380 | 1522 | 1 |
0.395 | 8746 | 1 |
Last trade - 14.37pm 04/09/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |